Welcome to the Molecular Glue Drug Development Summit!
Built with biopharmaceutical industry insights, this in-person meeting will bring together KOLs to delve deep into the key remaining challenges when it comes to identifying, designing and developing the next generation of molecular glues and truly unlock the widespread therapeutic potential of this promising therapy.
This forum will deliver exclusive data from the movers and shakers in the molecular glue space, from the likes of C4 Therapeutics, Monte Rosa Therapeutics, Amgen, Proxygen, Pin Therapeutics, Degron Therapeutics, Plexium and more.
Join the summit for a deep dive into new and emerging topics such as:
Reviewing the Novel Mechanisms of Newly Discovered Molecular Glues
Optimizing Rational Design of Next Generation Glues
Enhancing the Library Specific Screening & Identification Assays
As we continue enriching the design and development of molecular glues, network with 80+ leading Chemists, Biologists, Bioinformaticians, Structural Scientists & Computational Chemists at the world’s first-of-a-kind meeting to successfully accelerate the first wave of molecular glues into the clinic.
25+ Expert Speakers Include:
Ryan Potts
Executive Director & Chair, Head of Induced Proximity Platform, Research & Development Postdoc Program
Amgen Inc.
2023 Partners
Snapshot of 2023 Attending Companies
